Company Monitoring Page for Exelixis

latest headlines for company on cafepharma

Exelixis reports 1st-quarter loss, misses expectations
Yahoo/AP
Wed, 05/4/16 - 06:45 pm
Tags:
Exelixis, earnings
Exelixis reports fourth-quarter loss but tops expectations
Yahoo/AP
Mon, 02/29/16 - 11:57 pm
Tags:
Exelixis, earnings
Exelixis Rises on Positive Late-Stage Trial Results
24/7 Wall St
Mon, 02/1/16 - 11:17 pm
Tags:
Exelixis, cabozantinib, renal cell carcinoma, clinical trials
The Top 5 Best Performing Biotech Stocks of 2015
Motley Fool
Sat, 01/2/16 - 10:27 am
Tags:
biotech, Eagle Pharmaceuticals, Exelixis, Prothena, Anacor, Heron Therapeutics
The Best Biotech Stocks in 2015
Motley Fool
Mon, 12/28/15 - 09:58 am
Tags:
Eagle Pharmaceuticals, Exelixis, Prothena
[video]2 Healthcare Stocks That Dominated in 2015
Motley Fool
Mon, 12/28/15 - 09:50 am
Tags:
Portola Pharmaceuticals, Exelixis
3 Biotech Stocks Under $5 That Could Explode Higher in 2016
Motley Fool
Sun, 12/27/15 - 10:28 am
Tags:
Geron, Agenus, Exelixis
The FDA Approves Exelixis, Inc's New Cancer Drug
Motley Fool
Mon, 11/23/15 - 10:05 am
Tags:
FDA, Exelixis, Cotellic, melanoma
Exelixis Announces Presentation of Positive Overall Survival Results for COTELLIC™ in Combination with Vemurafenib in Advanced BRAF V600 Mutation-Positive Melanoma at Society for Melanoma Research 2015 International Congress
Yahoo
Sun, 11/22/15 - 10:49 am
Tags:
Exelixis, Cotellic, melanoma
Exelixis, Inc. Earnings: Riding the Meteor
Motley Fool
Mon, 11/16/15 - 11:50 am
Tags:
earnings, Exelixis
Genentech, Exelixis score another PhIII success for cobimetinib
Fierce Biotech
Tue, 10/6/15 - 09:59 am
Tags:
Genentech, Exelixis, Cobimetinib, melanoma, BRAF V600
Kidney Cancer Drug Boxing Match
Motley Fool
Mon, 10/5/15 - 09:17 am
Tags:
kidney cancer, Bristol-Myers Squibb, Novartis, Exelixis, Opdivo, Cometriq, Afinitor
10 Best Nasdaq Biotech Stocks in the Third Quarter
TheStreet.com
Wed, 09/30/15 - 07:49 pm
Tags:
Incyte, Myriad, Cara Therapeutics, Sucampo, ZS Pharma, Concert Pharmaceuticals, The Medicines Company, Lexicon Pharmaceuticals, Exelixis, Anacor
Cometriq Plays Wallflower As Opdivo's Dance Card Fills
Seeking Alpha
Mon, 09/28/15 - 08:23 am
Tags:
Bristol-Myers Squibb, Opdivo, Cometriq, Exelixis, kidney cancer
We Believe Healthcare's Next Biotech Buyout Target Is…
Motley Fool
Sun, 08/30/15 - 02:05 pm
Tags:
M&A, Biocryst, Biogen, Exelixis
FDA Grants Breakthrough Therapy Designation to Exelixis’ Cabozantinib for the Treatment of Renal Cell Carcinoma in Patients Who Received One Prior Therapy
Yahoo
Mon, 08/24/15 - 11:26 am
Tags:
FDA, Exelixis, breakthrough therapies, renal cell carcinoma, cabozantinib
Exelixis reports 2Q loss
Yahoo/AP
Tue, 08/11/15 - 06:55 pm
Tags:
earnings, Exelixis
5 Big FDA Decisions Expected in August
24/7 Wall St
Thu, 08/6/15 - 02:58 pm
Tags:
FDA, Exelixis, vemurafenib, aripiprazole lauroxil, Alkermes, evolocumab, Amgen, Bristol-Myers Squibb, Opdivo, Clovis Oncology, rociletinib
3 Biotech Stocks That Could Double Before 2016
Motley Fool
Sun, 07/26/15 - 08:45 pm
Tags:
Exelixis, Spark Therapeutics, Geron
Novartis bullish on Afinitor cancer drug despite new competition
Yahoo/Reuters
Tue, 07/21/15 - 06:52 pm
Tags:
Novartis, Afinitor, Opdivo, Cometriq, Exelixis, Bristol-Myers Squibb

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.